Related Experiment Videos
Diabetic control in community care. The use of clinical evaluation and hemoglobin A1
Insights
Glycosylated hemoglobin (HbA1) testing offers valuable insights into diabetic control, especially for patients with satisfactory management. Regular HbA1 monitoring provides crucial data beyond clinical evaluation.
Area of Science:
- Endocrinology
- Clinical Chemistry
Background:
- Diabetic control assessment relies on clinical judgment and biochemical markers.
- Glycosylated hemoglobin (HbA1) reflects long-term glycemic control.
Purpose of the Study:
- To evaluate diabetic control using clinical criteria and HbA1 determination.
- To compare different HbA1 measurement methods and their correlation with clinical assessment.
Main Methods:
- 50 diabetic patients' control was assessed clinically and via HbA1.
- HbA1 was measured using ion exchange chromatography and agar gel electrophoresis.
- Correlation between methods and clinical control levels was analyzed.
Main Results:
- Ion exchange chromatography and agar gel electrophoresis yielded similar HbA1 results.
- Good correlation was observed between pre- and post-labile fraction elimination HbA1 samples.
- No significant HbA1 differences were found across diet, hypoglycemic agents, or insulin treatment groups.
- Patients with satisfactory and poor control showed significantly higher HbA1 than those with good control.
Conclusions:
- The described HbA1 determination methods are reliable and yield similar results.
- Clinical evaluation is dependable for classifying good or poor diabetic control.
- Regular HbA1 monitoring offers significant additional information for patients with satisfactory control.
Abstract:
Diabetic control was evaluated in 50 consecutive patients attending a community care centre, either by clinical criteria or by determination of glycosylated hemoglobin (HbA1). Two methods used for the determination of HbA1 were found to give similar results, namely ion exchange chromatography and agar gel electrophoresis. On a group basis, good correlation was observed between HbA1 samples analysed prior to and following the elimination of the labile HbA1 fraction. When comparing three treatment modes (diet alone, hypoglycemic agents or insulin), no significant differences in HbA1 levels were noted. Patients considered to have satisfactory and poor control had significantly higher HbA1 levels than those considered to have good control, while no differences were seen between those considered to have satisfactory or poor control. It is concluded that the methods described for the determination of HbA1 yield similar results. Clinical evaluation of diabetic control is reliable in patients classified to have good or poor control. However, in many patients who are considered to have satisfactory control, regular determinations of HbA1 provide valuable additional information.